FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
(NEW YORK) -- The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved for the condition.The new, expanded Zepbound approval means that insurance providers,...
